Peak Bio, Inc. Retained Earnings
Peak Bio, Inc. had Retained Earnings of -$40.97 million as of 2024-09-30, per its 10-Q filed 2024-11-12.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2024-11-12
- 2024-09-30: Retained Earnings (Accumulated Deficit) -$40.97M.
- 2024-06-30: Retained Earnings (Accumulated Deficit) -$42.68M.
- 2024-03-31: Retained Earnings (Accumulated Deficit) -$40.61M.
- 2023-12-31: Retained Earnings (Accumulated Deficit) -$38.17M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2024-09-30 | -$40.97M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$42.68M 10-Q · filed 2024-08-23 | |
| 2024-03-31 | -$40.61M 10-Q · filed 2024-08-23 | |
| 2023-12-31 | -$38.17M 10-Q · filed 2024-11-12 | |
| 2023-09-30 | -$37.65M 10-Q · filed 2024-06-25 | |
| 2023-06-30 | -$38.06M 10-Q · filed 2023-08-18 | |
| 2023-03-31 | -$32.11M 10-Q · filed 2023-07-12 | |
| 2022-12-31 | -$25.35M 10-K · filed 2024-08-06 | |
| 2022-09-30 | -$1.93M 10-Q · filed 2022-11-21 | |
| 2022-06-30 | -$1.73M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | -$1.41M 10-Q · filed 2022-05-19 | |
| 2021-12-31 | -$8.45M 10-K · filed 2023-06-29 | -$2.01M 10-K · filed 2022-03-31 |
| 2021-09-30 | -$1.09M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$1.21M 10-Q · filed 2021-11-15 | $269.61K 10-Q · filed 2021-08-16 |
| 2021-03-31 | -$1.82M 10-Q · filed 2021-11-15 | -$346.49K 10-Q · filed 2021-07-26 |
| 2021-02-01 | -$1.48M 10-Q · filed 2021-11-15 | -$4.40K 10-Q · filed 2021-07-26 |
| 2020-12-31 | -$310.00 10-K · filed 2022-03-31 |